The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Kostyuk G.P.

Serbsky Federal Medical Research Center for Psychiatry and Narcology, Moscow, Russia, Institute of Medical and Social Technologies, Moscow, Russia, Alekseev Psychiatric Clinical Hospital №1, Moscow, Russia

Masyakin A.V.

Alexeev Clinical Psychiatric Hospital №1, Moscow, Russia

Burygina L.A.

Gannushkin Psychiatric Clinical Hospital №4, Moscow, Russia

Reverchuk I.V.

Izhevsk State Medical Academy, Izhevsk, Russia

The problem of diagnosis and treatment of depression by primary care physicians

Authors:

Kostyuk G.P., Masyakin A.V., Burygina L.A., Reverchuk I.V.

More about the authors

Read: 4719 times


To cite this article:

Kostyuk GP, Masyakin AV, Burygina LA, Reverchuk IV. The problem of diagnosis and treatment of depression by primary care physicians. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(1‑2):55‑61. (In Russ.)
https://doi.org/10.17116/jnevro20191191255

Recommended articles:
Using the index method to assess the primary health care staffing. Russian Journal of Preventive Medi­cine. 2024;(11):27-33
Digi­tal reality: Impact on the mental health of young people. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(10):12-17

References:

  1. Psychosomatic disorders in clinical practice. Ed. by Acad. of RAMS Smulevich AB. M.: MEDPress-inform; 2015. (In Russ.)
  2. Krasnov VN, Dovzhenko TV, Bobrov AE, Starostina EG. Psychiatry in primary health care: a new solution to the old problem. Social and Clinical Psychiatry. 2013;4:5-13. (In Russ.)
  3. WHO. The European Mental Health Action Plan. «Problems and solutions: the WHO European Ministerial Conference on Mental Health»; Helsinki, Finland. January 12—15, 2005. (In Russ.) Accessed October 6, 2017. Available at: http://c2n.biz/registration/content/ua1725/pages/f38909.pdf#page=14&zoom=auto,-178,788
  4. WHO. The European Mental Health Action Plan. «European Regional Committee, 63 session». Chetshe, Izmir, Turkey; September 16—19, 2013. (In Russ.) Accessed October 6, 2017. Available at: http://psychiatr.ru/download/1862?name=63wd11r_MentalHealth-3.pdf&view=1#page=30&zoom=auto,-98,814
  5. Copty M, Whitford DL. Mental health in general practice: assessment of current state and future needs. Irish Journal of Psychological Medicine. 2005;22(3):83-86.
  6. Kessler R. Mental health care treatment initiation when mental health services are incorporated into primary care practice. Journal of the American Board of Family Medicine. 2012;25(2):255-259.
  7. Van Rijswijk E, Borghuis M, van de Lisdonk E, Zitman F, van Weel C. Treatment of mental health problems in general practice: a survey of psychotropics prescribed and other treatments provided. International Journal of Clinical Pharmacology and Therapeutics. 2007;45(1):23-29.
  8. Harmon K, Carr VJ, Lewin TJ. Comparison of integrated and consultation-liaison models for providing mental health care in general practice in New South Wales, Australia. Journal of Advanced Nursing. 2000;32(6):1459-1466.
  9. Mitchell G, Del Mar C, Francis D. Does primary medical practitioner involvement with a specialist team improve patient outcomes? A systematic review. British Journal of General Practice. 2002;52(484):934-939.
  10. Wang PS, Berglund P, Olfson M, Pincus HA, Wells KB, Kessler RC. Failure and delay in initial treatment contact after first onset of mental disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry. 2005;62(6):603-613.
  11. Avedisova AS. Controlling anxiety symptoms and treating anxiety and phobic disorders — is an alternative or not? Psihiatriia i Psihofarmacoterapiia. 2006;8(5):3-6. (In Russ.)
  12. Oganov RG, Olbinskaya LI, Smulevich AB, Vejn AM, Drobigev MYu, Shalnova SA, Pogosova GV, Shurov AV. Depression and depressive spectrum disorders in general medical practice. Preliminary results of the KOMPAS program. Cardiologiia. 2004;1:48-55. (In Russ.)
  13. Aleksandrovsky YuA. Border mental disorder. A guide for physicians. 4th ed, revised and add. M. 2007. (In Russ.)
  14. Vertogradova OP. Anxious phobic disorders and depression. Anxiety and obsessions. Ed. Smulevich AB. M.: NTsPZ RAMS; 1998. (In Russ.)
  15. Guide to primary health care. Ed. by Baranova A, Denisova I, Chuchalina A. M.: GEOTAR-Media; 2006. (In Russ.)
  16. Reverchuk IV. Neurotic depression in the Slavs and Finno-Ugrians: nature, culture or illness. Sovremennie Naukoemkie Tehnologii. 2007;1:84-88. (In Russ.)
  17. Pignone MP, Gaynes BM, Rushton JL, Mills Burchell C, Orleans CT, Mulrow CD, Lohr KN. Screening for Depression in Adults: A Summary of the Evidencefor the U.S. Preventive Services Task Force. Annals of Internal Medicine. 2002;136:765-776.
  18. Marcus SC, Olfson M. National trends in the treatment for depression from 1998 to 2007. Arch Gen Psychiatry. 2010;67(12):1265-1273. https://doi.org/10.1001/archgenpsychiatry.2010.151
  19. Barlow D. Clinical guidelines for mental disorders. 3rd ed. Translation from English. M., SPb., N. Novgorod: Piter; 2008. (In Russ.)
  20. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington, DC: American Psychiatric Association; 2013.
  21. Schulberg HC, Katon W, Simon GE, Rush AJ. Treating major depression in primary care practice: an update of the Agency for Health Care Policy and Research Practice Guidelines. Archives of General Psychiatry. 1998;55:1121-1127.
  22. ICD-10. Classification of mental and behavioral disorders. Research diagnostic criteria. Geneva: World Health Organization; 1994. (In Russ.)
  23. Montgomery SA, Boer JA. SSRI in depression and anxiety. Chichester: John Wiley & Sons; 2001.
  24. Nutt D, Rickels K, Stein DJ. Generalized anxiety disorders symptomatology, pathogenesis and management. London: Martin Dunitz; 2002.
  25. Starcevic V. Anxiety disorders in adults. A clinical guide. Oxford: Oxford University Press; 2005.
  26. Stein DJ, Hollander E. Textbook of Anxiety Disorders. Washington: American Psychiatric Publishing; 2002.
  27. Stein D, Lorer B, Stahl St. Evidence-Based Psychopharmacology. Cambridg: Cambridge University Press; 2005.
  28. Hayashi T, Stahl SM. SIGMA-1 (σ1) receptors and their role in the treatment of affective disorders. Drugs of the Future. 2009;34:137-146.
  29. Ivanov MV. Fluvoxamine: Opportunities in drug therapy psychiatric disorders. Obozrenie Psihiatrii i Medicinskoi Psihologii. 2012;4:91-95. (In Russ.)
  30. Mandelli L. et al.Improvement of cognitive functioning in mood disorder patients with depressive symptomatic recovery during treatment: an exploratory analysis.Psychiatry Clin Neurosci. 2006 Oct;60(5):598-604
  31. Nishimura T, Ishima T, Iyo M, Hashimoto K. Potentiation of Nerve Growth Factor-Induced Neurite Outgrowth by Fluvoxamine: Role of Sigma-1 Receptors, IP3 Receptors and Cellular Signaling Pathways. PLoS ONE. 2008; 3(7): e2558. Published online 2008 July 2.
  32. Hartter S, Wang X, Weigmann H, et al. Differential effects of fluvoxamine and other antidepressants on the biotransformation of melatonin. J Clin Psychopharmacology. 2001;21:167-174.
  33. Gatti F, Bellini L, Gasperini M, Perez J, Zanardi R, Smeraldi E. Fluvoxamine alone in the treatment of delusional depression. Am J Psychiatry. 1996;153:414-416.
  34. Freeman C, Trimble M, Deakin J. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison. J Clin Psychiatry. 1994;55(7):301-315.
  35. Barlow DH, Campbell LA. Mixed anxiety-depression and its implications for models of mood and anxiety disorders. Compr Psychiatry. 2000;41(2 suppl 1):55-60.
  36. Papakostas GI, Fava M. Pharmacotherapy for depression and treatment-resistant depression. Hackensack, NJ: World Scientific; 2010.
  37. Cramer H, Lauche R, Langhorst J, Dobos G. Yoga for depression: A systematic review and meta-analysis. Depression and Anxiety. 2013;30:1068-1083.
  38. Pampallona S, Bollini P, Tibaldi G, Kupelnick B, Munizza C. Combined pharmacotherapy and psychological treatment for depression: a systematic review. Arch Gen Psychiatry. 2004;61:714-719.
  39. Ishak WW, Ha K, Kapitanski N, Bagot K, Fathy H, Swanson B, Vilhauer J, Balayan K, Bolotaulo NI, Rapaport MH. The impact of psychotherapy, pharmacotherapy, and their combination on quality of life in depression. Harv Rev Psychiatry. 2011;19:277-289.
  40. Raddock M, Martukovich R, Berko E, Delos Reyes C, Werner JJ. 7 tools to help patients adopt healthier behaviors. J Fam Pract. 2015;64:97-103.
  41. Castonguay LG, Constantino MJ, Holtforth MG. The working alliance: Where are we and where should we go? Psychotherapy (Chic). 2006;43:271-279.
  42. Greenberg RP, Constantino MJ, Bruce N. Are patient expectations still relevant for psychotherapy process and outcome? Clin Psychol Rev. 2006;26:657-678.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.